-
AASLD-IDSA HCV Guidance Panel, 2018. Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin. Infect. Dis. 67, 1477-1492.
-
Aghemo, A., Prati, G. M., Rumi, M. G., Soffredini, R., D'Ambrosio, R., Orsi, E., De Nicola, S., Degasperi, E., Grancini, V., & Colombo, M., 2012. Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C. Hepatology 56, 1681-1687.
-
Brandman, D., Bacchetti, P., Ayala, C. E., Maher, J. J., & Khalili, M., 2012. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care 35, 1090-1094.
-
Cacoub, P., Desbois, A. C., Comarmond, C., & Saadoun, D., 2018. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut 67, 2025-2034.
-
Carnevale Schianca, G. P., Rossi, A., Sainaghi, P. P., Maduli, E., & Bartoli, E., 2003. The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance. Diabetes Care, 26, 1333-1337.
-
Carnovale, C., Pozzi, M., Dassano, A., D'Addio, F., Gentili, M., Magni, C., Clementi, E., Radice, S., & Fiorina, P., 2019. The impact of a successful treatment of hepatitis C virus on glyco-metabolic control in diabetic patients: a systematic review and meta-analysis. Acta Diabetol. 56, 341-354.
-
Caronia, S., Taylor, K., Pagliaro, L., Carr, C., Palazzo, U., Petrik, J., O'Rahilly, S., Shore, S., Tom, B. D., & Alexander, G. J., 1999. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 30, 1059-1063.
-
Chen, J., Wang, N., Dong, M., Guo, M., Zhao, Y., Zhuo, Z., Zhang, C., Chi, X., Pan, Y., Jiang, J. et al., 2015. The metabolic regulator histone deacetylase 9 contributes to glucose homeostasis abnormality induced by hepatitis C virus infection. Diabetes 64, 4088-4098.
-
Defronzo, R. A., 2009. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58, 773-795.
-
Dong, T. S., Aby, E. S., Benhammou, J. N., Kawamoto, J., Han, S. H., May, F. P., & Pisegna, J. R., 2018. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c. World J. Hepatol. 10, 612-621.
-
Dreux, M., Garaigorta, U., Boyd, B., Decembre, E., Chung, J., Whitten-Bauer, C., Wieland, S., & Chisari, F. V., 2012. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558-570.
-
Dyal, H. K., Aguilar, M., Bartos, G., Holt, E. W., Bhuket, T., Liu, B., Cheung, R., & Wong, R. J., 2016. Diabetes mellitus increases risk of hepatocellular carcinoma in chronic hepatitis C virus patients: a systematic review. Dig. Dis. Sci. 61, 636-645.
-
Fletcher, N. F., Yang, J. P., Farquhar, M. J., Hu, K., Davis, C., He, Q., Dowd, K., Ray, S. C., Krieger, S. E., Neyts, J. et al., 2010. Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 139, 1365-1374.
-
Genuth, S., Alberti, K. G., Bennett, P., Buse, J., Defronzo, R., Kahn, R., Kitzmiller, J., Knowler, W. C., Lebovitz, H., Lernmark, A. et al., 2003. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160-3167.
-
Herzberg-Schafer, S. A., Staiger, H., Heni, M., Ketterer, C., Guthoff, M., Kantartzis, K., Machicao, F., Stefan, N., Haring, H. U., & Fritsche, A., 2010. Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired β-cell function. PLoS One 5, e14194.
-
Hsu, C. S., Liu, C. J., Liu, C. H., Wang, C. C., Chen, C. L., Lai, M. Y., Chen, P. J., Kao, J. H., & Chen, D. S., 2008. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver Int. 28, 271-277.
-
Iwasaki, Y., Ohkubo, A., Kajinuma, H., Akanuma, Y., & Kosaka, K., 1978. Degradation and secretion of insulin in hepatic cirrhosis. J. Clin. Endocrinol. Metab. 47, 774-779.
-
Kosaka, K., Kuzuya, T., Hagura, R., & Yoshinaga, H., 1996. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet. Med. 13, S109-S119.
-
Lecube, A., Hernandez, C., Genesca, J., & Simo, R., 2006. Glucose abnormalities in patients with hepatitis C virus infection: epidemiology and pathogenesis. Diabetes Care 29, 1140-1149.
-
Lorenzo, C., Wagenknecht, L. E., Rewers, M. J., Karter, A. J., Bergman, R. N., Hanley, A. J., & Haffner, S. M., 2010. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 33, 2098-2103.
-
Mahale, P., Engels, E. A., Li, R., Torres, H. A., Hwang, L. Y., Brown, E. L., & Kramer, J. R., 2018. The effect of sustained virological response on the risk of extrahepatic manifestations of hepatitis C virus infection. Gut 67, 553-561.
-
Masini, M., Campani, D., Boggi, U., Menicagli, M., Funel, N., Pollera, M., Lupi, R., Del Guerra, S., Bugliani, M., Torri, S. et al., 2005. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care 28, 940-941.
-
Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, F. G., Zimmerman, R. et al., 1999. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology, 29, 328-333.
-
Matsuda, M., & DeFronzo, R. A., 1999. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470.
-
Naing, C., Mak, J. W., Ahmed, S. I., & Maung, M., 2012. Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis. World J. Gastroenterol. 18, 1642-1651.
-
Narita, R., Abe, S., Kihara, Y., Akiyama, T., Tabaru, A., & Otsuki, M., 2004. Insulin resistance and insulin secretion in chronic hepatitis C virus infection. J. Hepatol. 41, 132-138.
-
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., Zinman, B., & American Diabetes, A., 2007. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30, 753-759.
-
Ohn, J. H., Kwak, S. H., Cho, Y. M., Lim, S., Jang, H. C., Park, K. S., & Cho, N. H., 2016. 10-year trajectory of β-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study. Lancet Diabetes Endocrinol. 4, 27-34.
-
Retnakaran, R., Shen, S., Hanley, A. J., Vuksan, V., Hamilton, J. K., & Zinman, B., 2008. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 16, 1901-1907.
-
Schlesinger, S., Neuenschwander, M., Barbaresko, J., Lang, A., Maalmi, H., Rathmann, W., Roden, M., & Herder, C., 2022. Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies. Diabetologia. 65, 275-285.
-
Seltzer, H. S., Allen, E. W., Herron, A. L., Jr., & Brennan, M. T., 1967. Insulin secretion in response to glycemic stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J. Clin. Invest. 46, 323-335.
-
Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., & Koike, K., 2004. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126, 840-848.
-
Stancakova, A., Javorsky, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M., 2009. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 58, 1212-1221.